Products

What will AGI do for Aminomethylbenzoic acid?

This classification denotes an antifibrinolytic with the molecular formula C8H9NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68WG9JKC7L, 4-aminomethylbenzoic acid or 4-Carboxybenzylamine, but generally known as aminomethylbenzoic acid, and which bears US NIH Compound Identifier 65526. European Medicines Agency schedules aminomethylbenzoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12854MIG. As of Q4 2014, AMINOMETHYLBENZOIC ACID remains the US FDA Preferred Term for this commodity. SMILES: C1=CC(=CC=C1CN)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Aminomethylbenzoic acid

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aminomethylbenzoic acid, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aminomethylbenzoic acid, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aminomethylbenzoic acid connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Heavy Metal Contentmodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Melting Point Rangemodel